Ami Bavishi

Ami is a seasoned investor relations (IR) and corporate communications leader with more than 10 years of experience in the field. She is responsible for overseeing Rallybio’s IR and communications efforts, including shaping the company’s IR and communications strategies. Prior to joining Rallybio, Ami was Director of Investor Relations at Aerie Pharmaceuticals Inc., where she oversaw all investor relations activities. Prior to Aerie, she held positions of increasing responsibility at Burns McClellan, a life sciences investor relations and public relations firm, including Vice President of Investor Relations. At Burns McClellan, Ami oversaw day-to-day investor relations and communications activities for multiple biotechnology companies. Ami also has experience as a business development professional at U.K. Trade and Investment, the business development arm of the U.K. government, where she sourced and developed bilateral investment and trade in the U.S. and U.K. life science sectors. She earned her bachelor’s degree in biological sciences from Duquesne University and a master’s degree in public health from The George Washington University.